US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Report updated on 11th September, 2021: Global Bacillus Coagulans Market 2021 (Includes Business Impact of COVID-19)Global Bacillus Coagulans Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global bacillus coagulans market report has been segmented on the basis of type, application, and region. Request Covid - 19 Impact The global Bacillus Coagulans market size was valued at USD$346.21 million in 2020 and is projected to reach USD $619.37 million by 2030, and is anticipated to expand at a CAGR of 6.87% over the forecast period from 2020 to 2030.
Global Bacillus Coagulans Market: OverviewBacillus Coagulans is a type of beneficial bacteria called as probiotic, that is majorly utilized for its probiotic nature. It improves gut health and slows the onset of stomach and digestive disorders. Some applications of bacterium in products such as bakery, beverages, dairy, confectionery, animal feed and functional food. Bacillus Coagulans used for various treatments such as digestive problems, lactose intolerance diarrhea, constipation, cholesterol reduction, bacterial vaginosis, and immunity enhancement. It is compatible with vitamins, electrolytes, enzymes, proteins, and carbohydrates, that makes it a cost-effective probiotic and used across wide range of food products.
Global Bacillus Coagulans Market: DynamicsTechnological advancements in probiotics industry is a key factor expected to drive growth of the global market over the forecast period. In addition, rising obese population across the globe and prevalence of non-communicable diseases are some other factors expected to further fuel growth of the target market over the forecast period. Moreover, increasing health awareness among consumers and increasing demand for bacillus coagulans products in emerging economies are some other factors expected to propel growth of the target market over the forecast period. However, stringent government regulations regarding the approval of probiotics is a key factor expected to restrain growth of the global market over the forecast period. Increasing health concerns among individuals and rising demand for functional foods across the globe are expected to create lucrative opportunities for the players operating in the global market over the forecast period. In addition, increasing investments by manufacturers for research and development activities of new probiotics products and launch of related new products are expected to create opportunities for the target market. Manufacturers operating in the target market increasing focus on development of innovative products and improve their product offering by strategic business activities such as mergers, acquisitions, etc. which will support growth of the global market over the forecast period.
Global Bacillus Coagulans Market: Segment AnalysisAmong the product segments, the food type segment is expected to register significant growth in terms of revenue over the forecast period. Among the application segments, the functional food segment is expected to register significant growth in terms of revenue and it is expected to continue its significance over the forecast period.
Global Bacillus Coagulans Market: Regional AnalysisThe market in North America is expected to dominate in the global market in terms of revenue over the forecast period, owing to increasing hectic lifestyle of working people and changing their eating habits which in turn is expected to increase their focus towards nutritional food products across various countries in this region. The market in Asia Pacific is expected to register significant growth over the forecast period, owing to increasing incidences of chronic disorders and growing obese population across various countries in this region.
Below are the active patents related to Bacillus Coagulans Market.Patent Number: US8492127B2 Bacillus coagulans strains and their applications in L-lactic acid production Abstract The invention is concerned with the strains of B. coagulans for lactic acid production and the related methods, in which the carbon sources are pentose or hexose or the agricultural or industrial wastes containing pentose or hexose or a mixture of both. According to the invention, the highest amount of L-lactic acid produced from glucose is 173 g/L, the optical purity is over 99%, the yield is up to 0.98, and the productivity is up to 2.4 g/L per hour. The highest amount of L-lactic acid produced from xylose is 195 g/L, the optical purity is over 99%, the yield is up to 0.98, and the productivity is up to 2.7 g/L per hour. The highest amount of L-lactic acid produced from reducing sugars in xylitol byproducts is 106 g/L, the optical purity is over 99%, and the productivity is up to 2.08 g/L per hour. The B. coagulans strains XZL4 (DSM No. 23183) and XZL9 (DSM No. 23184) of the invention can directly utilize various reducing sugars in xylitol byproducts to produce high amounts of L-lactic acid, which improves the production efficiency at low costs, and the strains are, thus, appropriate for industrial productions. Application File Date: 2010-11-22 Application Granted Date: 2013-07-23 Current Assignee: Shanghai Jiaotong University Patent Number: US20160074495A1 Inactivated Bacterial Cell Formulation Abstract The invention relates to the use of lactic acid-producing bacteria to boost the immune system. Application File Date: 2015-11-23 Application Granted Date: 2016-09-20 Current Assignee: Ganeden Biotech Inc
Global Bacillus Coagulans Market Segmentation:Segmentation by product:
Table of Contents Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data SourcesChapter 2. Executive SummaryChapter 3. Global Bacillus Coagulans Market Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects, 2016 - 2027 3.3. Value Chain Analysis 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis | read more...